Breast and Cervical Cancer Awareness Training in Visually Impaired Women (NCT07541859) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Breast and Cervical Cancer Awareness Training in Visually Impaired Women
Turkey (Türkiye)74 participantsStarted 2026-06
Plain-language summary
This quasi-experimental study aims to determine whether a breast and cervical cancer awareness training program can increase participation in cancer screening among women with visual impairments. The study also aims to identify barriers to screening and improve knowledge about cancer risk factors and screening methods. The main questions this study will address are:
* Does the training increase the rate at which women with visual impairments attend cancer screening appointments?
* Does the training improve participants' knowledge about breast and cervical cancer?
Participants will:
* Receive training on breast and cervical cancer risk factors and screening methods.
* Learn how to apply to the Cancer Early Diagnosis, Screening, and Training Center.
* Be encouraged to attend cancer screening during the study period.
* Have knowledge and screening status assessed before the training, immediately after, and three months later.
Who can participate
Age range
40 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Eligibility Criteria
Inclusion Criteria:
* Women with only a visual impairment (congenital or acquired)
* Able to communicate, speak, and understand Turkish
* Voluntarily agree to participate in the study
* Over the age of 40
* Have had previous sexual intercourse (Pap smear screening requires sexual activity)
Exclusion Criteria:
* Diagnosed with breast or cervical cancer
* Under the age of 40
* Have not had sexual intercourse before
* Have undergone screening for at least one of these two cancer types (breast or cervical) within the last year
According to the Turkish Ministry of Health, General Directorate of Public Health, in current screenings conducted in our country, within the breast cancer screening program for women, mammography is recommended every two years for women aged 40-69, and within the cervical cancer screening program, Pap smear and HPV-DNA tests are recommended every five years for women aged 30-65. Since women will be referred by the researchers to KETEM centers after training to undergo mammography and Pap smear screening tests, visually impaired women over the age of 40 who have previously had sexual intercourse will be included in the study, as these two screening tests are performed in this common age group and Pap smear screening requires being sexually active.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Cancer Screening Uptake Rate
Timeframe: Post-test (immediately after the training), follow-up test (3 months later).